Studies of multimerin in patients with von Willebrand disease and platelet von Willebrand factor deficiency

被引:6
作者
Chen, CI
Federici, AB
Cramer, EM
Canciani, MT
Harrison, P
Zheng, SL
Massé, JM
Mannucci, PM
Hayward, CPM
机构
[1] McMaster Univ, Dept Pathol, Hamilton, ON L8N 3Z5, Canada
[2] McMaster Univ, Dept Lab Med, Hamilton, ON L8N 3Z5, Canada
[3] McMaster Univ, Dept Med, Hamilton, ON L8N 3Z5, Canada
[4] Hamilton Hlth Sci Corp, Hamilton, ON, Canada
[5] Maggiore Hosp, IRCCS, Angelo Bianchi Bonomi Haemophilia & Thrombosis Ct, Milan, Italy
[6] Maggiore Hosp, IRCCS, Inst Internal Med, Milan, Italy
[7] Univ Milan, Milan, Italy
[8] Hop Henri Mondor, INSERM, U91, F-94010 Creteil, France
[9] UCL Hosp, Dept Haematol, London, England
关键词
platelets; von Willebrand factor; von Willebrand disease; multimerin; granules;
D O I
10.1046/j.1365-2141.1998.00943.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In normal platelet alpha-granules von Willebrand factor (VWF) is stored with multimerin and factor V in an eccentric electron-lucent zone. Because the platelet stores of VWF are deficient in 'platelet low' type 1 and type 3 von Willebrand disease (VWD), we investigated their electron-lucent zone proteins. The patients with VWD had partial to complete deficiencies of plasma and platelet VWF but normal alpha-granular multimerin and factor V, and normal alpha-granular fibrinogen, thrombospondin-1, fibronectin, osteonectin and P-selectin. In type 3 VWD platelets, alpha-granular electron-lucent zones lacking VWF-associated tubules were identified and multimerin was found in its normal alpha-granular location, These findings indicate that the formation of the electron-lucent zone and the sorting of multimerin to this region occur independent of VWF. The isolated abnormalities in VWF suggests a VWF gene mutation is the cause of 'platelet low' type 1 VWD.
引用
收藏
页码:20 / 28
页数:9
相关论文
共 54 条
[1]   TRANSPLANTATION OF NORMAL BONE-MARROW INTO A PIG WITH SEVERE VONWILLEBRANDS DISEASE [J].
BOWIE, EJW ;
SOLBERG, LA ;
FASS, DN ;
JOHNSON, CM ;
KNUTSON, GJ ;
STEWART, ML ;
ZOECKLEIN, LJ .
JOURNAL OF CLINICAL INVESTIGATION, 1986, 78 (01) :26-30
[2]  
CASTILLO R, 1991, BLOOD, V77, P1901
[3]   ROLE FOR PLATELET VONWILLEBRAND-FACTOR IN SUPPORTING PLATELET-VESSEL WALL INTERACTIONS IN VONWILLEBRAND DISEASE [J].
CASTILLO, R ;
ESCOLAR, G ;
MONTEAGUDO, J ;
ORDINAS, A ;
GARRIDO, M ;
MOIA, M ;
FEDERICI, AB ;
MANNUCCI, PM .
AMERICAN JOURNAL OF HEMATOLOGY, 1989, 31 (03) :153-158
[4]  
CRAMER EM, 1985, BLOOD, V66, P710
[5]  
CRAMER EM, 1988, BLOOD, V71, P1533
[6]  
CRAMER EM, 1985, BLOOD, V66, P1309
[7]  
CRAMER EM, 1986, BLOOD, V68, P774
[8]  
DALESSIO P, 1990, THROMB HAEMOSTASIS, V64, P227
[9]   Dominant type 1 von Willebrand disease caused by mutated cysteine residues in the D3 domain of von Willebrand factor [J].
Eikenboom, JCJ ;
Matsushita, T ;
Reitsma, PH ;
Tuley, EA ;
Castaman, G ;
Briet, E ;
Sadler, JE .
BLOOD, 1996, 88 (07) :2433-2441
[10]  
EWENSTEIN BM, 1990, BLOOD, V75, P1466